Clinical Trial Update: Talactoferrin in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer or Squamous Cell Head and Neck Cancer [Phase 1]

View source ↗

Summary

This clinical trial update reports on a Phase 1 study of talactoferrin in patients with relapsed or refractory non-small cell lung cancer or squamous cell carci…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer
• Squamous Cell Carcinoma of the Head and Neck

Drugs mentioned

• Talactoferrin (talactoferrin)

Snippet

Sponsor: Stanford University | Conditions: Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With Occult Primary | Phase 1 | Status: TERMINATED